Basho Chandan 4
4 · Astrana Health, Inc. · Filed Apr 3, 2026
Research Summary
AI-generated summary of this filing
Astrana Health (ASTH) COO/CFO Basho Chandan Sells 2,092 Shares
What Happened Basho Chandan, Astrana Health’s COO and CFO, surrendered 2,092 shares on April 2, 2026 to satisfy tax withholding obligations tied to restricted stock units that vested. The shares were valued at $25.05 each, for a total of $52,405. This was a tax-withholding share surrender (Form 4 transaction code F), not an open-market sale.
Key Details
- Transaction date and price: April 2, 2026 — 2,092 shares at $25.05 each (= $52,405).
- Transaction type: Code F — shares surrendered to cover tax withholding for vested RSUs.
- Filing date: April 3, 2026 (filed promptly the next day).
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Relevant footnotes:
- F1: Confirms shares were surrendered to offset tax withholding on RSUs that vested April 2, 2026.
- F2: Lists remaining unvested equity: 7,214 restricted shares vesting April 14, 2026; 30,404 restricted shares vesting in two equal annual installments on May 16, 2026 and 2027; 15,604 RSUs vesting in four equal semi-annual installments beginning Oct 2, 2026; and 20,027 RSUs vesting in six equal semi-annual installments beginning Sept 5, 2026.
Context This transaction is a routine tax-withholding event tied to vesting and should not be read as a market-timing sale. Such surrenders are common when executives receive vested equity and elect (or are required) to have shares withheld to cover payroll taxes.
Insider Transaction Report
Form 4
Basho Chandan
COO and CFO
Transactions
- Tax Payment
Common Stock
[F1][F2]2026-04-02$25.05/sh−2,092$52,405→ 171,635 total
Footnotes (2)
- [F1]Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on April 2, 2026.
- [F2]Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 7,214 shares, which will vest on April 14, 2026; and (ii) 30,404 shares, which will vest in two equal annual installments on May 16, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026.
Signature
/s/ Kathy Diep, as Attorney-in-Fact|2026-04-03